Evidence map›Paper›PMID 35925390›Full record

ArticleVirchows Archiv : an international journal of pathology2022

TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases.

Natálie Klubíčková, Michael Michal, Abbas Agaimy, Nina Zidar, Michal Pavlovský, Kenji Yorita, Petr Grossmann, Veronika Hájková, Nikola Ptáková, Petr Šteiner and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular pathology in diagnosis and prognostication of head and neck tumors.Virchows Archiv : an international journal of pathology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Natálie KlubíčkováDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic. klubickova@biopticka.cz.ORCID http://orcid.org/0000-0002-4407-5544
Michael MichalDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic.
Abbas AgaimyInstitute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen (UKER), Erlangen, Germany.
Nina ZidarInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Michal PavlovskýDepartment of Pathology, Regional Hospital Most, Most, Czech Republic.
Kenji YoritaDepartment of Diagnostic Pathology, Japanese Red Cross Kochi Hospital, Kochi, Japan.
Petr GrossmannBioptical Laboratory, Ltd., Pilsen, Czech Republic.
Veronika HájkováBioptical Laboratory, Ltd., Pilsen, Czech Republic.
Nikola PtákováBioptical Laboratory, Ltd., Pilsen, Czech Republic.
Petr ŠteinerBioptical Laboratory, Ltd., Pilsen, Czech Republic.
Michal MichalDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic.
Biopticka Laborator (Czechia) · CZCharles University · CZFriedrich-Alexander-Universität Erlangen-Nürnberg · DEJapanese Red Cross Kochi Hospital · JPUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report 7 cases of an indolent, variably myxoid tumor of the vocal cords, characterized by overt cellular atypia with large cells containing intranuclear and intracytoplasmic vacuoles, delicate curvilinear vessels, and sparse inflammatory infiltrate. Six patients were male, aged 15 to 65 years, and 1 patient was a 54-year-old female. All tumors were located in the superficial portion of the vocal cord. One patient suffered a recurrence that was completely resected; all patients with available follow-up data currently have no evidence of disease. The tumors contained alternating areas with myxoid stroma and more compacted regions with tumor cells organized in short fascicles, interwoven with delicate curvilinear vasculature. Overt cellular atypia with large cells containing intranuclear and intracytoplasmic vacuoles or resembling ganglion cells was present in all cases but mitoses and necrosis were absent. ALK immunostaining was positive in all cases, while most tumors were negative for smooth muscle actin. Targeted RNA-sequencing revealed an identical TIMP3::ALK fusion with exon 1 of TIMP3 gene being fused with exon 12 of ALK gene in all analyzable cases. For various reasons discussed, it remains unclear whether this tumor represents a mere subtype of IMT or a separate entity. Nevertheless, it is a morphologically distinct and diagnostically challenging lesion that needs to be recognized by surgical pathologists in order to prevent overdiagnosis in this clinically very delicate area.

Indexed as

Biomarkers, TumorVocal CordsFemaleGene FusionHumansImmunohistochemistryMaleMiddle AgedProteoglycansReceptor Protein-Tyrosine KinasesTissue Inhibitor of Metalloproteinase-3Biomarkers, TumorProteoglycansReceptor Protein-Tyrosine KinasesTIMP3 protein, humanTissue Inhibitor of Metalloproteinase-3Inflammatory myofibroblastic tumorLarynxMyxoid fibroblastic tumorSoft tissuesTIMP3::ALKVocal cords

Identifiers

PMID35925390
OpenAlexW4289767046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.